Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia

Journal of Neural Transmission

Volumn 105, Issue 6-7, 1998, Pages 719-734

  Lahti, A C ^a,c   Weiler, M ^a   Carlsson, A ^b   Tamminga, C A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Antipsychotic; D3 antagonist; Dopamine; Schizophrenia; UH232

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; AUTORECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE RECEPTOR BLOCKING AGENT; DRD3 PROTEIN, HUMAN; DRUG DERIVATIVE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HOSTILITY; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; THINKING; TREATMENT OUTCOME; BEHAVIOR; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PSYCHOLOGY; STEREOISOMERISM; TIME;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADULT; AUTORECEPTORS; BEHAVIOR; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STEREOISOMERISM; TIME FACTORS;

EID: 0031593972     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050091     Document Type: Article

References (50)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci 93: 1945-1949
2. Andreasen NC (1982) Negative symptoms of schizophrenia: definitions and reliability. Arch Gen Psychiatry 39: 784-788
3. Astrachan BM, Harrons M, Adler D, Brauer L, Schwartz A, Tucker G (1972) A checklist for the diagnosis of schizophrenia. Br J Psychiatry 121(564): 529-539
4. Brog JS, Salyapongse A, Deutch AY, Zahm DS (1993) The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J Comp Neurol 338: 255-278
5. 2 dopamine receptor cDNA. Nature 336: 783-787
6. Cannon-Spoor HE, Potkin SP, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8: 470-484
7. 2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse - implications for psychosis. J Neural Transm [Gen Sect] 100: 225-237
8. Cassady SL, Thaker GK, Summerfelt A, Tamminga CA (1997) The Maryland Psychiatric Research Center scale and the characterization of involuntary movements. Psychiatry Res 70: 21-37
9. 2 dopamine receptors. Mol Pharmacol 45: 51-60
10. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607-1619
11. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drues. Science 192: 481-483
12. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6: 1384-1387
13. 3 receptor ligand, (+)-UH232, is a partial agonist. Eur J Pharmacol 282: R3-R4
14. Groenewegen HJ, Becker NEHM, Lohman AHM (1980) Subcortical afferents of the nucleus accumbens septi in the cat, studied with retrograde axonal transport of horseradish peroxidase and bisbenzimid. Neuroscience 5: 1903-1916
15. 3 receptors and use of antipsychotics in patients with schizophrenia. Arch Gen Psychiatry 54: 225-232
16. Kelley AE, Domesick VB (1982) The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde-and retrograde-horseradish peroxidase study. Neuroscience 7: 2321-2335
17. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30: 119-123
18. Kita H, Kitai ST (1990) Amygdaloid projections to the frontal cortex and the striatum in the rat. J Comp Neurol 298: 40-49
19. 2-family receptor distribution in human postmortem tissue: an autoradiographic study. NeuroReport 6: 2505-2512
20. 4 receptors in human postmortem brain sections: comparison between normals and schizophrenics. Schizophr Res 18: 173
21. 3H]-NGD-94-1 Binding in human postmortem brain of normals and schizophrenics off-, or on-antipsychotic drugs at death. Schizophr Res 24: 35
22. 3 receptor mRNA and binding sites in human brain. Brain Res. Mol Brain Res 18: 187-189
23. Meador-Woodruff JH, Grandy DK, Van Tol HHM, Damask SP, Little KY, Civelli O, Watson SJ (1994) Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10(4): 239-248
24. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ (1996) Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15: 17-29
25. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91: 11271-11275
26. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15: 2186-2191
27. O'Donnell P, Grace AA (1995) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15(5): 3622-3639
28. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10: 799-812
29. Piercey MF, Lum JT (1990) Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ76 and (+)-UH232. Eur J Pharmacol 182: 219-226
30. 3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur J Pharmacol Mol Pharmacol Sect 268: 129-139
31. 4 receptors in drug-treated schizophrenia. Eur J Pharmacol 281: R5-R6
32. Robertson GS, Fibiger HC (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46: 315-328
33. 3 receptor and its relevance in psychiatry. Int Clin Psychopharmacol 10 [Suppl 3]: 15-20
34. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717-719
35. 4 receptors are elevated in schizophrenia. Nature 365: 441-445
36. Skarsfeldt T (1988) Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine of SNC and VTA dopamine neurons in rats. Life Sci 42(10): 1037-1044
37. 3) as a target for neuroleptics. Nature 347: 146-151
38. 2 receptor. Eur J Pharmacol Mol Pharmacol Sect 225: 331-337
39. 3 dopamine receptor. Eur Neuropsychopharmacol 3: 232-234
40. Spitzer RL, Williams JBW, Gibbon M (1987) Structured clinical interview for DSM-III-R (SCID). New York State Psychiatric Institute, Biometrics Research Department
41. Strauss JS, Carpenter WT (1974) The prediction of outcome in schizophrenia. Arch Gen Psychiatry 31: 37-42
42. Svensson A, Carlsson M, Carlsson A (1991) Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ76 and (+)-UH232 with regard to locomotor stimulation in monoamine-depleted mice. J Neural Transm [Gen Sect] 85: 69-77
43. Svensson K, Hjorth S, Clark D, Carlsson A, Wilkstrom H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U, Nilsson JLG (1986) (+)-UH232 and (+)-UH242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. J Neural Transm 65: 1-27
44. Svensson K, Johansson AM, Magnusson T, Carlsson A (1986) (+)-AJ76 and (+)-UH232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 334: 234-245
45. 3, receptors. Eur J Pharmacol 263: 235-243
46. Tamminga CA, Schaffer MH (1979) Treatment of schizophrenia with ergot derivatives. Psychopharmacol 66: 239-242
47. Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL (1986) Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine. Arch Gen Psychiatry 43: 398-402
48. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614
49. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm [Gen Sect] 94: 11-19
50. Zahm DS, Brog JS (1992) On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50: 751-767